PCN61 US BUDGET IMPACT ANALYSIS OF BENDAMUSTINE READY-TO-DILUTE PRODUCTS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA

Autor: James, E., Trautman, H., Szabo, E., Ribalov, R.
Zdroj: In Value in Health May 2020 23 Supplement 1:S34-S34
Databáze: ScienceDirect